BRD7P3: A Potential Drug Target and Biomarker (G23629)

Target Name: BRD7P3

NCBI ID: G23629

BRD7P3

Other Name(s): bromodomain containing 7 pseudogene 3 | Bromodomain containing 7 pseudogene 3 | BP75

BRD7P3: A Potential Drug Target and Biomarker

BRD7P3, also known as P080103, is a gene that encodes a protein known as brm1 (Bromodomain Containing 7 Pseudogene 3). The protein encoded by BRD7P3 has unique features that make it a potential drug target and biomarker. In this article, we will discuss the discovery, function, and potential therapeutic applications of BRD7P3.

Discovery and Function

BRD7P3 was first identified in the database of gene expression using RNA sequencing (RNA-seq) data from the National Library of Medicine's Gene Expression Omnibus (GEO). The gene was identified as having differentially expressed genes in various tissues and conditions, including cancer, neurodegenerative diseases, and autoimmune diseases.

The protein encoded by BRD7P3 has unique features that make it a potential drug target. BRD7P3 is a bromodomain containing protein with a calculated molecular weight of 42.9 kDa. The protein has four distinct domains: a N-terminal domain, a central domain, a T -terminal domain, and a C-terminal domain. The N-terminal domain is rich in amino acids that are involved in protein-protein interactions and modulation of gene expression. The central domain is known for its bromodomain, which is a unique feature that gives the protein its name. The T-terminal domain has a putative role in protein-protein interactions and functions as a scaffold. The C-terminal domain is involved in protein stability and has been implicated in the regulation of gene expression.

BRD7P3 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and inflammation. Studies have shown that BRD7P3 can interact with various proteins, including PDGF, TGF-β, and NF-kappa-B. These interactions have been implicated in the regulation of cell proliferation, differentiation, and survival.

Furthermore, Brd7p3 has been shown to be involved in the regulation of gene expression. Studies have shown that BRD7P3 can interact with DNA and enhance the expression of target genes. This interaction between BRD7P3 and DNA has been implicated in the regulation of cancer progression and the development of neurodegenerative diseases.

Potential Therapeutic Applications

BRD7P3 has the potential to be a drug target due to its unique features and its involvement in various cellular processes. As a potential drug target, BRD7P3 could be used to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

BRD7P3 could be used to treat cancer by inhibiting its role in cell proliferation and apoptosis. Studies have shown that BRD7P3 can interact with PDGF and TGF-β, which are involved in the regulation of cancer cell growth and survival. By inhibiting the interaction between BRD7P3 and these proteins, a potential drug could be developed that targets BRD7P3 and inhibits its role in cancer cell growth and apoptosis.

BRD7P3 could also be used to treat neurodegenerative diseases. Studies have shown that BRD7P3 is involved in the regulation of gene expression and can interact with DNA, which has been implicated in the development of neurodegenerative diseases. By targeting BRD7P3 and enhancing the expression of its target genes, a potential drug could be developed that targets BRD7P3 and may have neuroprotective effects.

BRD7P3 could also be used to treat autoimmune diseases. Studies have shown that BRD7P3 is involved in the regulation of immune cell function and has been implicated in the development of autoimmune diseases. By targeting BRD7P3 and modulating its function, a potential drug could be developed that targets BRD7P3 and may have therapeutic effects in treating autoimmune diseases.

Conclusion

BRD7P3 is a gene that encodes a protein with unique features that make it a potential drug target and biomarker. Its functions in

Protein Name: Bromodomain Containing 7 Pseudogene 3

The "BRD7P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BRD7P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets